ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.360
-0.120 (-3.45%)
At close: May 14, 2026, 4:00 PM EDT
3.360
0.00 (0.00%)
After-hours: May 14, 2026, 7:00 PM EDT
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $427.36 million as of May 14, 2026. Its market cap has increased by 203.45% in one year.
Market Cap
427.36M
Enterprise Value
632.61M
1-Year Change
203.45%
Ranking
Category
Stock Price
$3.36
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $427.36M, a decrease of -79.08%. That is a compound annual growth rate of -22.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 442.63M | 1.22% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 455.40M |
| Zura Bio | 450.68M |
| Enanta Pharmaceuticals | 448.64M |
| Lyell Immunopharma | 447.98M |
| Monopar Therapeutics | 438.47M |
| PureTech Health | 437.17M |
| Atea Pharmaceuticals | 432.95M |
| Verastem | 428.82M |